Results 231 to 240 of about 160,452 (346)

Oral MIB‐626 (β Nicotinamide Mononucleotide) Safely Raises Blood Nicotinamide Adenine Dinucleotide Levels in Hospitalized Patients With COVID‐19 and Acute Kidney Injury: A Randomized Controlled Trial

FASEB BioAdvances, EarlyView.
This randomized, placebo‐controlled trial assessed the effects of NAD augmentation by administration of oral β Nicotinamide Mononucleotide (β NMN) 1.0 g twice daily or placebo for 14 days in adult patients hospitalized with COVID‐19 and acute kidney injury on blood NAD, plasma levels of NAD metabolites, biomarkers of acute kidney injury, inflammation ...
Karol M. Pencina, David E. Leaf, Rodrigo J. Valderrabano, Sushrut S. Waikar, Tapan S. Mehta, Yili Valentine Shang, Nancy K. Latham, Tejossy John, Elena Volpi, Dahlene Fusco, Yusnie Memish‐Beleva, Shobana Krishnamurthy, Siva Lavu, Salma Karmi, David J. Livingston, Shalender Bhasin   +15 more
wiley   +1 more source

Arthropathy due to parvovirus B19 infection in an adult. [PDF]

CMAJ
Kano Y.
europepmc   +1 more source

Does Low‐Value Care Explain Health Care Utilization Inequities Among Asian and Latino Populations?

Health Services Research, EarlyView.
ABSTRACT Objectives To examine differences in the utilization of low‐value care among Asian and Latino subpopulations compared to the White population. Study Setting and Design We analyzed data from a repeated cross‐sectional national survey. Data Sources and Analytical Sample Our sample included a non‐Latino White population and Asian and Latino ...
Sungchul Park, Jie Chen, Arturo Vargas Bustamante, Alexander N. Ortega   +3 more
wiley   +1 more source

Future trends in the development of safer nonsteroidal anti-inflammatory drugs

, 1998
M. Michael Wolfe
openalex   +1 more source

Nicotinamide Riboside Supplementation Benefits in Patients With Werner Syndrome: A Double‐Blind Randomized Crossover Placebo‐Controlled Trial

Aging Cell, EarlyView.
Nicotinamide riboside improved arterial stiffness (cardio–ankle vascular index), reduced skin ulcer area, and showed a trend toward mitigating heel pad thinning in patients with Werner syndrome, with no serious adverse events. Metabolomic analysis revealed a significant decrease in creatinine, suggesting a potential suppression of renal functional ...
Mayumi Shoji, Hisaya Kato, Masaya Koshizaka, Hiyori Kaneko, Yusuke Baba, Takahiro Ishikawa, Naoya Teramoto, Daisuke Kinoshita, Ayano Yamaguchi, Yukari Maeda, Yosuke Inaba, Yuki Shiko, Yoshihito Ozawa, Vilhelm A. Bohr, Yoshiro Maezawa, Koutaro Yokote   +15 more
wiley   +1 more source

Efficacy of cyclin-dependent kinases 4 and 6 inhibitors in the treatment of HR +/HER2 - advanced breast cancer: a meta-analysis. [PDF]

Eur J Med Res
Danbala IA, Wang X, Su Y, Tang H, Sheng W, Shaibu Z, Isah I, Yuan X.   +7 more
europepmc   +1 more source

Implementation of geriatric clinical decision support in the emergency department for potentially inappropriate medications

Academic Emergency Medicine, EarlyView.
Abstract Objectives The use of potentially inappropriate medications (PIMs) in older adults in the emergency department (ED) is associated with increased risk of readmissions and adverse drug reactions. We sought to assess the impact of electronic health record (EHR)‐based geriatric clinical decision support (CDS) on adherence to geriatric ...
Gina A. Elder, Kevin King, Marc Willner, Matthew J. Campbell, Baruch S. Fertel, Saket Saxena, Stephen Meldon   +6 more
wiley   +1 more source

Chronic kidney disease is no longer a 'non-traditional' cardiac risk factor: a call to action for cardiovascular-kidney-metabolic health. [PDF]

Singapore Med J
Fong JMN, Sia CH, See KC.
europepmc   +1 more source

Nonsteroidal Treatment Osteoporosis

Journal of the Korean Medical Association, 2000
openaire   +2 more sources

Embedding Pharmacogenetics Into Clinical Practice to Improve Patient Outcomes

Annals of Human Genetics, EarlyView.
ABSTRACT Pharmacogenomics, the use of germline genomic data to guide prescription to improve effective and safer medication, holds promise as a clinical intervention. To date in most health systems, there has been limited uptake of pharmacogenomic testing confined to a few single drug–gene associations.
John Henry McDermott, Videha Sharma, Jessica Keen, William Gerard Newman   +3 more
wiley   +1 more source